Siyue Song

Siyue Song

Auto-generated profile, based on publicly available information

Siyue Song

College of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SSSiyue Song
Siyue Song
MFMoqi Fan
Moqi Fan
XWXianghui Wen
Xianghui Wen
XSXiaowei Shi
Xiaowei Shi
YLYu Lou
Yu Lou
TSTiejuan Shao
Tiejuan Shao

Verified
Journal Article
Open access
PDF file
YJYuepeng Jiang
Yuepeng Jiang
JWJun-Jun Wen
Jun-Jun Wen
XZXiaoxuan Zhao
Xiaoxuan Zhao
YGYuan-Cheng Gao
Yuan-Cheng Gao
XMXiao Ma
Xiao Ma
CWCheng-Ping Wen
Cheng-Ping Wen
Rheumatoid arthritis (RA) is a progressive autoimmune disease. Due to local infiltration and damage to the joints, activated CD4+ T cells play a crucial role in the progression of RA. However, the exact regulatory mechanisms are perplexing, which makes the effective management of RA frustrating. This study aimed to investigate the effect of mitochondria fission on the polarization and migration of CD4+ T cells as well as the regulatory mechanism of NAR, so as to provide enlightenment on therapeutic targets and novel strategies for the treatment of RA. In this study, a collagen-induced arthritis (CIA) model was established, and rats were randomly given saline or naringenin (NAR, 10 mg/kg, 20 mg/kg, 50 mg/kg, i.p.) once a day, before being euthanized on the 42nd day of primary immunization. The pain-like behavior, articular index scores, account of synovial-infiltrated CD4+ T cells, and inflammatory factors were investigated in each group. In vitro, spleen CD4+ T lymphocytes were derived from each group. In addition, mitochondrial division inhibitor 1 (Mdivi-1) or NAR was added to the cell medium containing C-X-C motif chemokine ligand 12 (CXCL12) in order to induce CD4+ T lymphocytes, respectively. The polarization capacity of CD4+ T cells was evaluated through the immunofluorescence intensity of the F-actin and myosin light chain phosphorylated at Ser19 (pMLC S19), and the mitochondrial distribution was determined by co-localization analysis of the translocase of outer mitochondrial membrane 20 (TOM20, the mitochondrial marker) and intercellular adhesion molecule 1 (ICAM1, the uropod marker). The mitochondrial fission was investigated by detecting dynamin-related protein 1 (Drp1) and mitochondrial fission protein 1 (Fis1) using Western blot and immunofluorescence. This study revealed that high-dose NAR (50 mg/kg, i.p.) alleviated pain-like behavior and articular index scores, reduced the serum level of interleukin 6 (IL-6) and tumor necrosis factor α (TNF-α), and accounted for CD4+ T lymphocytes that infiltrated into the synovial membrane of the CIA group. Meanwhile, NAR (50 mg/kg, i.p.) suppressed the polarization of spleen CD4+ T lymphocytes, reduced the redistribution of mitochondria in the uropod, and inhibited the expression of Drp1 and Fis1 in the CIA model. Furthermore, the in vitro experiments confirmed that NAR reduced mitochondrial fission, which in turn inhibited the CXCL12-induced polarization and migration of CD4+ T lymphocytes. Our results demonstrated that the flavonoid NAR was a promising drug for the treatment of RA, which could effectively interfere with mitochondrial fission, thus inhibiting the polarization and migration of CD4+ T cells in the synovial membrane.

1 January 2023 in SSRN Electronic Journal
Verified
Preprint
Open access
SSSiyue Song
Siyue Song
MFMoqi Fan
Moqi Fan
XWXianghui Wen
Xianghui Wen
XSXiaowei Shi
Xiaowei Shi
YLYu Lou
Yu Lou
TSTiejuan Shao
Tiejuan Shao
Ethnopharmacological relevance: Qu-zhuo-tong-bi decoction (QZTBD) is a classic Chinese herbal medicine that has shown therapeutic efficacy in clinical practice against gout. However, the potential mechanism of QZTBD remain poorly investigated.Aim of the study: To assess the therapeutic effects of QZTBD on gout and to reveal its mechanisms of action.Materials and Methods: A Uox-KO mouse model of hyperuricemia and gout was established, and QTZBD was administered at a dosage of 18.0 g/kg/d. Throughout the experimental period, the effects of QZTBD on gout symptoms were monitored and analyzed. The integrated network pharmacology and gut microbiota analysis strategy was conducted to explore the mechanism of QZTBD in the treatment of hyperuricemia and gout. Targeted amino acid metabolomic analysis was conducted to investigate the relationship between the gut microbiome and amino acid metabolism. Flow cytometry was used to analysis the proportion of Th17 and Treg cells, and the production of pro-inflammatory cytokines was measured by ELISA to evaluate the inflammatory status.Results: QZTBD treatment showed remarkable efficacy against gout with respect to attenuation of disease activity metrics through gut microbiome recovery and intestinal immune homeostasis. The administration of QZTBD significantly elevated the abundance of Allobaculum and Candidatus sacchairmonas, corrected the aberrant amino acid patterns, repaired the impaired intestinal barrier, restored the balance of Th17/Treg cells both in intestine and spleen, and reduced the levels of inflammatory cytokines such as IL-1β, IL-6, TNF-α and IL-17. Fecal microbiota transplantation from QZTBD treated mice demonstrated convincing evidence of efficacy and mechanism of QZTBD.Conclusion: Taken together, our study explores the therapeutic mechanism of an effective herbal formula, QZTBD, for gout treatment through remodeling gut microbiome and regulating the differentiation of CD4+ T cells via AKT-mTOR pathway.